152 related articles for article (PubMed ID: 36684548)
1.
Salah NY; Ali HGA; Bassiouny N; Salem L; Taha SI; Youssef MK; Annaka L; Barakat NM
J Pediatr Genet; 2023 Mar; 12(1):16-22. PubMed ID: 36684548
[TBL] [Abstract][Full Text] [Related]
2. Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia.
Dadheech S; Madhulatha D; Jainc S; Joseph J; Jyothy A; Munshi A
Indian J Med Res; 2016 Apr; 143(4):449-54. PubMed ID: 27377501
[TBL] [Abstract][Full Text] [Related]
3. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
[TBL] [Abstract][Full Text] [Related]
5. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between hemoglobin F levels and single nucleotide polymorphism at BCL11A gene rs11886868 locus in β-thalassemia patients].
Chen QR; Sun SC; Peng YS; Wang Q; Mo BM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):650-3. PubMed ID: 22739175
[TBL] [Abstract][Full Text] [Related]
7. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
8. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
[TBL] [Abstract][Full Text] [Related]
9. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
[TBL] [Abstract][Full Text] [Related]
10. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
11. Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.
Dadheech S; Jain S; Madhulatha D; Sharma V; Joseph J; Jyothy A; Munshi A
Mol Biol Rep; 2014 May; 41(5):3331-7. PubMed ID: 24488321
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major.
Tantawy AA; Andrawes NG; Ismaeil A; Kamel SA; Emam W
Ann Saudi Med; 2012; 32(5):487-91. PubMed ID: 22871617
[TBL] [Abstract][Full Text] [Related]
13. Responses of β-thalassemia and compound heterozygote of Sickle/βthalassemia of BCL11A Gene Polymorphism in Pakistani Patients.
Soomro N; Wahid M; Mehmood M; Danish SH
Pak J Med Sci; 2023; 39(6):1788-1792. PubMed ID: 37936787
[TBL] [Abstract][Full Text] [Related]
14. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
[TBL] [Abstract][Full Text] [Related]
15. An Aγ-globin G->A gene polymorphism associated with β
Breveglieri G; Bianchi N; Cosenza LC; Gamberini MR; Chiavilli F; Zuccato C; Montagner G; Borgatti M; Lampronti I; Finotti A; Gambari R
BMC Med Genet; 2017 Aug; 18(1):93. PubMed ID: 28851297
[TBL] [Abstract][Full Text] [Related]
16. BCL11A Down-Regulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells.
Li J; Lai Y; Shi L
Hemoglobin; 2018 Jul; 42(4):225-230. PubMed ID: 30821197
[TBL] [Abstract][Full Text] [Related]
17. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Mar; ():1-5. PubMed ID: 26125973
[TBL] [Abstract][Full Text] [Related]
18. Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in β-thalassemia and sickle cell disease: A comparative meta-analysis.
Quagliano A; Acevedo D; Hardigan P; Prasad S
Front Med (Lausanne); 2022; 9():943631. PubMed ID: 36250099
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]